Mersana Therapeutics buy Citigroup Inc.
Start price
17:00
/
50%
€1.27
Target price
27.08.25
€4.48
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 27.08.25. The prediction end date can be changed by Citigroup_Inc_ at any time.Performance without dividends (%)
Name | 1w |
---|---|
Mersana Therapeutics | - |
iShares Core DAX® | 1.056% |
iShares Nasdaq 100 | -1.886% |
iShares Nikkei 225® | 2.553% |
iShares S&P 500 | -0.434% |
Comments by Citigroup_Inc_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target lowered by analysts at Citigroup Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.71
04.12.23
04.12.23
€4.61
04.12.24
04.12.24
-16.99%
22.08.24
22.08.24